SCHEMBL5312420

SCHEMBL5312420

CC1CN(C(=O)OC(C)(C)C)CCC1n1ccc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.46
USP30 Q70CQ3 8/20 0.44
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
PRKCG P05129 1/20 0.42
PRKCB P05771 1/20 0.42
PRKCA P17252 1/20 0.42
PRKCH P24723 1/20 0.42
PRKCE Q02156 1/20 0.42
PRKCD Q05655 1/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
STS P08842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27616629 1.00 GPR119 (0.46) GPR119USP30JAK2JAK1PRKCG
SCHEMBL4985438 0.88 GPR119 (0.43) GPR119USP30JAK2JAK1KDM4E
SCHEMBL4989406 0.87 GPR119 (0.42) GPR119USP30JAK2JAK1KDM4E
SCHEMBL5253699 0.84 MAPT (0.46) GPR119USP30JAK2JAK1KDM4E
SCHEMBL3159082 0.83 GPR119 (0.52) GPR119PRKCGPRKCBPRKCAPRKCH
SCHEMBL4993042 0.81 SMN1; SMN2 (0.38) GPR119USP30JAK2JAK1KDM4E
SCHEMBL4993039 0.81 GPR119 (0.38) GPR119USP30JAK2JAK1PRKCG
SCHEMBL25176769 0.81 NAMPT (0.44) GPR119USP30PRKCGPRKCBPRKCA
SCHEMBL30958420 0.77 GPR119 (0.43) GPR119PRKCGPRKCBPRKCAPRKCH
SCHEMBL30958418 0.77 GPR119 (0.43) GPR119PRKCGPRKCBPRKCAPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487822-B1 PYRROLE-2,5-DIONE DERIVATIVES AND THEIR USE AS GSK-3 INHIBITORS LILLY CO ELI (US) 2007-08-01 EP disclosed
CN-1639152-A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors LILLY CO ELI (US) 2005-07-13 CN disclosed